Stay updated with breaking news from External Link. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The U.S. Food and Drug Administration (FDA) has issued a Letter to Health Care Providers about updated information associated with paclitaxel-coated devices used to treat peripheral arterial disease (PAD)
While no devices are being recalled, here's what patients need to know.
The tablets are being recalled due to the presence of a nitrosamine, Nnitroso-quinapril, above the ADI level
The tablets are being recalled due to the presence of a nitrosamine, Nnitroso-quinapril, above the ADI level
The avalanche danger was rated high (4 out of 5) across much of Colorado on Tuesday, spanning from Summit County to the north to the southern San Juans. The Colorado Avalanche Information Center report Tuesday...